Hoth Therapeutics, Inc. Contracts & Agreements
86 Contracts & Agreements
- Business Finance (40 contracts)
- Business Operations (2)
- Human Resources (16)
- Intellectual Property (7)
- Uncategorized (21)
- Form of Warrant (Filed With SEC on March 28, 2024)
- Form of Warrant Inducement Agreement (Filed With SEC on March 28, 2024)
- Form of New Warrant (Filed With SEC on March 28, 2024)
- Form of Inducement Letter (Filed With SEC on March 28, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on September 15, 2023)
- Form of Warrant (Filed With SEC on September 15, 2023)
- Form of Placement Agent Warrant (Filed With SEC on September 15, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on September 15, 2023)
- Description of the Registrants Securities (Filed With SEC on March 31, 2023)
- Renewal Agreement with Regus dated July 22, 2022 (Filed With SEC on March 31, 2023)
- Employment Agreement by and between the Company and Robb Knie dated as of March 28, 2023 (Filed With SEC on March 31, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on December 30, 2022)
- Form of Common Stock Warrants (Filed With SEC on December 30, 2022)
- Form of Pre-Funded Warrants (Filed With SEC on December 30, 2022)
- Form of Registration Rights Agreement (Filed With SEC on December 30, 2022)
- Form of Placement Agent Warrants (Filed With SEC on December 30, 2022)
- Separation Agreement and General Release by and between the Company and Stefanie Johns dated December 9, 2022 (Filed With SEC on December 13, 2022)
- Third Amendment to Employment Agreement by and between the Company and Stefanie Johns dated November 10, 2022 (Filed With SEC on November 10, 2022)
- Subscription and Investment Representation Agreement dated November 2, 2022 (Filed With SEC on November 3, 2022)
- Underwriting Agreement, dated April 11, 2022, by and between Hoth Therapeutics, Inc. and EF Hutton, division of Benchmark Investments, LLC (Filed With SEC on April 13, 2022)
- Description of the Registrants Securities (Filed With SEC on March 30, 2022)
- First Amendment to the Amended and Restated Employment Agreement between Hoth Therapeutics, Inc. and Robb Knie dated June 25, 2021 (Filed With SEC on June 30, 2021)
- Second Amendment to the Employment Agreement between Hoth Therapeutics, Inc. and Stefanie Johns dated June 25, 2021 (Filed With SEC on June 30, 2021)
- First Amendment to the Amended and Restated Employment Agreement between Hoth Therapeutics, Inc. and Jane Springer dated June 25, 2021 (Filed With SEC on June 30, 2021)
- Description of the Registrants Securities (Filed With SEC on March 16, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on March 9, 2021)
- Form of Common Stock Warrants (Filed With SEC on March 9, 2021)
- Form of Pre-Funded Warrants (Filed With SEC on March 9, 2021)
- Form of Registration Rights Agreement (Filed With SEC on March 9, 2021)
- Form of Placement Agent Warrants (Filed With SEC on March 9, 2021)
- First Amendment to the Employment Agreement between Hoth Therapeutics, Inc. and Stefanie Johns (Filed With SEC on January 29, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on January 8, 2021)
- Form of Warrant (Filed With SEC on January 8, 2021)
- Form of Registration Rights Agreement (Filed With SEC on January 8, 2021)
- Form of Placement Agent Warrant (Filed With SEC on January 8, 2021)
- Sponsored Research Agreement by and between the Company and the George Washington University (Filed With SEC on September 21, 2020)
- Employment Agreement by and between the Company and Stefanie Johns dated August 28, 2020 (Filed With SEC on August 31, 2020)
- License Agreement by and between the University of Cincinnati and Chelexa BioSciences, Inc. dated February 27, 2013 assigned to the Company on May 14, 2020 (Filed With SEC on August 13, 2020)
- First Amendment to Exclusive License Agreement by and between the University of Cincinnati and Chelexa BioSciences, Inc. dated April 17, 2013 assigned to the Company on May 14,... (Filed With SEC on August 13, 2020)
- Second Amendment to Exclusive License Agreement by and between the University of Cincinnati and Chelexa BioSciences, Inc. dated February 27, 2013 assigned to the Company on May... (Filed With SEC on August 13, 2020)
- Assignment and Assumption Agreement by and between the Company and Chelexa BioSciences, Inc. dated May 14, 2020 (Filed With SEC on August 13, 2020)
- Royalty Agreement by and between the Company and Chelexa BioSciences, Inc. dated May 14, 2020 (Filed With SEC on August 13, 2020)
- Novation Agreement by and among the Company, Chelexa BioSciences, Inc. and the University of Cincinnati dated May 14, 2020 (Filed With SEC on August 13, 2020)
- Patent License Agreement by and between the Company and the George Washington University dated August 7, 2020 (Filed With SEC on August 13, 2020)
- Sublicense Agreement by and between the Company and Isoprene Pharmaceutics, Inc. dated July 30, 2020 (Filed With SEC on August 5, 2020)
- Sponsored Project Agreement by and between the Company and Virginia Commonwealth University (Filed With SEC on July 2, 2020)
- Membership Interest Purchase Agreement by and between the Company and HaloVax, LLC dated May 28, 2020 (Filed With SEC on May 29, 2020)
- Underwriting Agreement, dated May 21, 2020, by and between Hoth Therapeutics, Inc. and The Benchmark Company, LLC (Filed With SEC on May 22, 2020)
- Form of Warrant (Filed With SEC on May 22, 2020)
- Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated May 18, 2020 (Filed With SEC on May 19, 2020)
- Underwriting Agreement, dated March 24, 2020, by and between Hoth Therapeutics, Inc. and Laidlaw & Company (UK) Ltd (Filed With SEC on March 25, 2020)
- Form of Warrant (Filed With SEC on March 25, 2020)
- Development and Royalty Agreement by and between the Company and Voltron Therapeutics, Inc. dated March 23, 2020 (Filed With SEC on March 23, 2020)
- Membership Interest Purchase Agreement by and between the Company and HaloVax, LLC dated March 23, 2020 (Filed With SEC on March 23, 2020)
- Renewal Agreement with Regus dated May 2, 2019 (Filed With SEC on March 2, 2020)
- License Agreement with North Carolina State University dated November 20, 2019 (Filed With SEC on March 2, 2020)
- Amended and Restated Employment Agreement by and between the Company and Jane Behrmann (Filed With SEC on November 12, 2019)
- Exclusive Sublicense Agreement between the Company and Zyl Therapeutics, Inc (Filed With SEC on August 23, 2019)
- Form of Subscription Agreement (Filed With SEC on August 21, 2019)
- Form of Unit Purchase Agreement (Filed With SEC on August 21, 2019)
- Form of Warrant (Filed With SEC on August 21, 2019)
- Form of Registration Rights Agreement (Filed With SEC on August 21, 2019)
- Form of Placement Agent Warrant (Filed With SEC on August 21, 2019)
- Employment Agreement by and between Hoth Therapeutics, Inc. and David Briones (Filed With SEC on March 7, 2019)
- Amended and Restated Employment Agreement, by and between Hoth Therapeutics, Inc. and Robb Knie (Filed With SEC on February 20, 2019)
- Form of Underwriting Agreement (Filed With SEC on January 11, 2019)
- Form of Underwriter Warrant (Filed With SEC on January 11, 2019)
- Form of Underwriting Agreement (Filed With SEC on December 14, 2018)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on December 14, 2018)
- Robb Knie Employment Agreement dated June 1, 2017 (Filed With SEC on December 14, 2018)
- Amendment to Robb Knie Employment Agreement dated August 4, 2017 (Filed With SEC on December 14, 2018)
- Form of Amended and Restated Employment Agreement between Hoth Therapeutics, Inc. and Robb Knie, to be effective on the closing of the offering contemplated by this registration... (Filed With SEC on December 14, 2018)
- Sublicense Agreement with Chelexa Biosciences, Inc. dated May 26, 2017 (Filed With SEC on December 14, 2018)
- License Agreement with the University of Cincinnati dated May 18, 2018 (Filed With SEC on December 14, 2018)
- Amended and Restated Stockholders Agreement dated October 25, 2017 (Filed With SEC on December 14, 2018)
- Office Service Agreement with Regus dated June 26, 2017 (Filed With SEC on December 14, 2018)
- Form of Warrant (Filed With SEC on December 14, 2018)
- Form of Unit Purchase Agreement (Filed With SEC on December 14, 2018)
- Form of Investor Rights Agreement (Filed With SEC on December 14, 2018)
- 2018 Equity Incentive Plan (Filed With SEC on December 14, 2018)
- Renewal Agreement with Regus dated April 9, 2018 (Filed With SEC on December 14, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on December 14, 2018)
- Form of Registration Rights Agreement (Filed With SEC on December 14, 2018)
- Amendment No. 1 to Sublicense Agreement with Chelexa Biosciences, Inc. dated August 22, 2018 (Filed With SEC on October 10, 2018)
- Amendment No. 2 to Sublicense Agreement with Chelexa Biosciences, Inc. dated August 29, 2018 (Filed With SEC on October 10, 2018)
- Form of Amendment and Restated Employment Agreement between Hoth Therapeutics, Inc. and Jane H. Behrmann, to be effective on the closing of the offering contemplated by this... (Filed With SEC on October 10, 2018)
